drugset
drugset / Trial / NCT04941755

A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants

NCT04941755 ↗

Phase 1 Completed 22 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to investigate the effect of gastric pH changes induced by famotidine on the drug levels of BMS-986256.

Timeline

Start
2021-06-25
Primary completion
2021-09-24
Completion
2021-09-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Afimetoran Small molecule — —
Subject Famotidine Other / unclassified — —

Indications

No indication recorded.